Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mailing Lanrui is a biotechnology company specializing in high-throughput single-cell sequencing and spatial multi-omics technologies. Based in Suzhou's BioBAY, the company provides comprehensive solutions that include sample processing, sequencing, and advanced bioinformatics analysis. Their proprietary platforms allow for the detailed characterization of cellular heterogeneity and spatial architecture within tissues. These services are primarily utilized by pharmaceutical companies and academic institutions to advance research in oncology, immunology, and neuroscience. Mailing Lanrui is dedicated to empowering precision medicine through high-resolution biological insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 迈麟蓝锐.